Man Group PLC Eli Lilly & CO Put Options Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $8.26 Million - $10.4 Million	11,400 Added 66.67%	28,500 $25.8 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $1.24 Million - $1.66 Million	-2,100 Reduced 10.94%	17,100 $13.3 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $10.1 Million - $11.9 Million	19,200 New	19,200 $11.2 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $332,400 - $409,064	1,500 Added 1500.0%	1,600 $370,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $18,055 - $23,354	100 New	100 $23,000

3,965

751M

6.32M

8.66M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $771B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.